Sensitivity analyses of IL-33 serum levels in nondiabetic individuals with obesity versus healthy controls involving the exclusion of individual studies in the comparison group of individuals with obesity versus healthy controls revealed notable changes in the pooled MD and heterogeneity measures (Table 6). This evidence concerns the gene IL33 and Obesity.